Nivolumab is used in the treatment of non-small cell lung cancer, kidney cancer, head and neck cancer, melanoma, Hodgkin's disease, and liver cancer.
How Nivolumab works Nivolumab is an anti-cancer medication that functions by blocking a protein known as PD-1 on the surface of specific immune cells called T-cells. This action activates the T-cells, enabling them to identify and destroy cancer cells.
Common side effects of Nivolumab include musculoskeletal pain (bone, muscle, or joint), upper respiratory tract infection, fever, pneumonia, bronchitis (inflammation of the airways), infusion site reaction, hypersensitivity, decreased levels of thyroid hormones, hyperthyroidism, inflammation of the thyroid gland, increased blood glucose levels, hypoglycemia (low blood glucose level), peripheral neuropathy (tingling and numbness in the feet and hands), cardiac disturbances, gastrointestinal disturbances, colitis, stomatitis (inflammation of the mouth), joint pain, fatigue, edema (swelling), chest pain, increased aspartate aminotransferase, low albumin levels in the blood, increased alkaline phosphatase levels in the blood, decreased white blood cell count (lymphocytes), decreased white blood cell count (neutrophils), low blood platelets, and electrolyte imbalance.
Nivolumab 40mg

₹39,800
Nivolumab 100mg

₹99,500
Nivolumab 40mg

₹39,800
Nivolumab 40mg

₹39,800